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Perinatal depression is a severe mental disorder that is greatly underdiagnosed and rarely 
treated in the United States. There are five main forms of perinatal depression: baby blues, 
postpartum depression, postpartum anxiety, postpartum panic disorder, and postpartum psychosis. 
Tools have been created to help obstetric providers screen for potential depressive symptoms in 
pregnant and postpartum women, but these are not used as often as recommended by the American 
College of Obstetrics and Gynecologists. This study, utilizing data collected by University of 
Pittsburgh Medical Center Magee-Womens Research Hospital in Pittsburgh, Pennsylvania, from 
2011-2015, analyzes audio recordings of the first comprehensive visit for pregnant women. The 
primary goals of this study are to determine if providers are asking women about their mental 
health history and educating their patients on perinatal and postpartum depression, and if patients 
are disclosing current or previous mental illness to their providers. This study found that most 
patients are not being properly screened by providers for depressive symptoms and are rarely being 
educated on the risks of perinatal and postpartum depression. Universal standards need to be 
established for all women to receive ample screening, education, and treatment for all forms of 
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1.0 Introduction  
Perinatal depression is defined by the National Institute of Mental Health as a mood 
disorder that can affect women both during and after their pregnancy ("Perinatal Depression," 
2020). Depression that occurs after newborn delivery is often referred to as postpartum depression, 
or PPD. Approximately 12-20% of all mothers suffer from symptoms of perinatal and postpartum 
depression within the first year of delivery (Avalos et al., 2016). These statistics are not precise as 
research has found that over half of all women who are afflicted with PPD are never diagnosed, 
and those who are diagnosed rarely receive any form of treatment (Zauderer, 2009). 
This paper presents a review of literature on the various forms of perinatal depression, as 
well as research conducted on the physiological effects and repercussions of related mental 
illnesses. Research has found that perinatal and postpartum depression are more likely to occur 
and have prolonged severity in women with low socioeconomic status, less education, and a 
history of mental illness. Age, race, and financial resources also play a significant role in whether 
women are properly diagnosed and treated for their mental illness in the United States (U.S.) 
(Ghaedrahmati et al., 2017).  
Perinatal depression can impact women for years after giving birth. Mothers who 
experience long-term symptoms are at a higher risk for experiencing mental and physical 
conditions that can negatively impact their quality of life. These mothers tend to report having 
fewer social interactions, poor relationships with family members and friends, and are more likely 
to develop additional mental illnesses and chronic health conditions (Groer & Morgan, 2007; 
Muzik & Borovska, 2010).   
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 Perinatal and postpartum depression not only impact new mothers, but the partners and 
children of these mothers as well. When mothers experience depression during their pregnancy, 
they are more likely to give birth prematurely and have a baby that is born underweight or with 
other medical complications (Muzik & Borovska, 2010). Children raised by depressed mothers are 
also at a greater risk for developing their own mental illnesses and behavioral issues, as well as 
experiencing intellectual difficulties (Groer & Morgan, 2007; "Maternal depression and child 
development," 2004). 
Male partners of women with PPD were found to be 2.5 times more likely to develop 
paternal depression once their partner begins displaying symptoms (Matthey et al., 2000). 
Relationships involving two partners who are experiencing depressive symptoms tend to have 
more difficulties, conflicts, and a perceived increase in burden in regard to caring for the child 
(Johansson et al., 2020; Roux et al., 2002).   
The paper then describes findings from an analysis of data collected through UPMC 
Magee-Womens Research Hospital from 2011-2015 at the first comprehensive visit a woman had 
with her obstetric care provider (Chang et al., 2017). This data included audio-recorded first 
obstetric visit conversations between pregnant patients and their obstetric care providers, as well 
as medical record abstraction from the pregnancy care records. A mixed-methods approach was 
taken; we used qualitative coding to describe and categorize mental health conversations and then 
performed quantitative analyses to explore associations between communication approaches and 
patient-provider characteristics and pregnancy outcomes.  Our team studied these visits by coding 
the transcripts and organizing our analysis in the program NVIVO. 
The participant pool consisted of 80 pregnant women who were visiting their obstetric care 
provider for the first time. We also studied the providers themselves to understand how 
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communication methods and rapport building skills impact the conversations surrounding mental 
health in pregnancy. Our providers were divided up by their clinical specialties: physicians, nurse 
practitioners, and nurse midwives. All participants were asked comprehensive health history 
questions by their providers and given a physical exam. Our study explored how often providers 
asked their patients about their mental health history to determine if certain provider types were 
more or less likely to initiate this conversation with their patients.  
The American College of Obstetricians and Gynecologists (ACOG) strongly recommends 
that all women be screened for depressive symptoms by their providers at the first obstetric care 
visit (ACOG, 2018). Contrary to these guidelines, this study found that most participants were not 
being asked about their mental health history by their providers. Providers at these clinics were 
supposed to administer the Edinburgh Pre/Postnatal Depression Scale (EPDS) at the first visit to 
determine depression risk, yet only 55 of the 80 participants had these results recorded in their 
medical charts.  
The EPDS consists of 10 questions designed to detect minor, moderate, or severe levels of 
depressive symptoms in patients. If a patient scored less than an 8 on the EPDS, depression was 
deemed to be not likely. The highest score a patient could get was a 30 (Chang et al., 2017). A 
score between 9 and 11 showed possible depression, 12-13 determined a fairly high probability of 
depression, and 14 and above demonstrated probable depression. Current standards are that all 
patients should be educated on perinatal and postpartum depression, regardless of their score, but 
those who scored higher on the scale are deemed to be more at risk ("ACOG Committee Opinion 
No. 757: Screening for Perinatal Depression," 2018; Chaudron et at., 2010). 
This study found that most patients were not being properly screened for depressive 
symptoms by their providers. Only nine of the 80 participants were given an opportunity to engage 
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in a discussion about maternal depression, meaning that women from this study were not being 





2.0 Overview of Perinatal Depression 
The term “perinatal depression” encompasses depression that is experienced during 
pregnancy, as well as depression that arises after delivery, referred to as postpartum depression 
(PPD). PPD can also be broken down into various categories such as “baby blues,” which affects 
up to 75% of new mothers after the first two weeks of delivery. Baby blues are a mild mood 
disorder and while it is considered normal after delivery, 25% of women who experience baby 
blues develop more intense depressive symptoms that follow them well after the first few weeks 
of motherhood (Thurgood et al., 2009).  
PPD and postpartum anxiety are severe mood disorders that can be attributed to drastic 
hormone changes and can present through feelings of excessive guilt or sadness, lack of interest 
in the child, changes in appetite, hopelessness, and lack of pleasure in once enjoyable activities. 
More severe forms of PPD can lead to postpartum obsessive-compulsive disorder, panic disorder, 
and psychosis. These are less common but can be extremely dangerous for the well-being of the 
mother, the baby, and the family itself. Postpartum obsessive-compulsive disorder has an incidence 
rate between 4 and 11%, with the highest number of cases being found two weeks after delivery 
(House et al., 2016). 
 Postpartum panic disorder is thought to afflict approximately 10% of all new mothers, yet 
current data may underrepresent women of all racial, ethnic, and financial backgrounds. This 
disorder in particular receives little attention because new mothers are often taught that they will 
naturally be more nervous after they become a parent, and many serious symptoms that can lead 
to postpartum psychosis are ignored. Postpartum psychosis has a 5% suicide and 4% infanticide 
rate, and while it occurs after only .002% of deliveries, maternal suicide is now the leading cause 
 
 6 
of maternal mortality in the U.S. and screenings for this level of PPD are often inadequate 
(Zauderer, 2009).   
Prior to 2006, most research on perinatal depression focused on the idea that maternal 
depression developed and was present in the postpartum period, while more recent research has 
shown that it may not be as simple as once thought. It may be true for a percentage of women that 
the trauma of delivery, extreme hormone changes, fatigue, and other significant factors cause an 
onset of depression after delivery, but recent data have shown that the majority of women 
diagnosed with PPD experienced depressive symptoms while still pregnant (Wilcox et al., 2020).  
A study by Wilcox et al. (2020) followed 1179 pregnant women in the U.S. in a 
longitudinal study analyzing the effects that pregnancy had on the mental health and the overall 
well-being of women in the healthcare system. This study used the Edinburgh Postnatal 
Depression Scale (EPDS), an instrument used to recognize depressive symptoms in perinatal and 
postpartum women, to assess the level of depression experienced by the women both during and 
after their pregnancy. This study found that 80% of all cases of perinatal depressive symptoms 
occurred during pregnancy, and 1/3 of those women experienced the symptoms in the first 
trimester (Wilcox et al., 2020). Twenty seven percent of all women included in this study 
experienced depression at some point either during or after their pregnancy, while only 11% of 
these women screened positive at the baseline assessment. 
Another longitudinal study (Pop et al., 2019) conducted in the Netherlands over a 25-year 
period, sought to find if perinatal depression had been increasing, decreasing, or remaining 
stagnant over time. The participants in this study were also screened with the EPDS and were split 
into four cohorts. From 1988 to 2014, the percentage of women who completed higher education 
jumped from 23 to 66%, the percentage of women actively working rose from 75 to 95%, and 
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smoking and alcohol usage had decreased in a similarly significant fashion. Even with these 
perceived positive changes in social and economic factors of human health, the number of women 
who screened positive for perinatal depression doubled from 7 to 14% over the last two decades. 
Protective factors for pregnancy, such as economic stability and lower rates of substance use, 
increased significantly over the course of the study, yet diagnoses of PPD were increasing (Pop et 
al., 2019).  
Perinatal depression is the most common complication seen in pregnancy and childbirth, 
and it is likely that current statistics on this subject are not accurate. More than half of all cases of 
PPD in the U.S. go undiagnosed due to a variety of factors such as misunderstandings of the 
disorder itself,  inaccurate or untimely screenings completed by medical providers, and the stigma 
surrounding mental health and motherhood (Zauderer, 2009). Two studies conducted over the past 
decade (Edge, 2010; Kozhimannil et al., 2013) found that some new mothers are unwilling to 
disclose depressive symptoms to providers or even family members due to the conventional idea 
that motherhood is supposed to be joyous, and feelings of disconnectedness, sadness, and the desire 
to self-harm make you a “bad mother.” 
Perinatal depression can affect women of all ages and races, yet there is a difference in the 
level of diagnosis and treatment for PPD among women of color (Edge, 2010). A 2013 
retrospective cohort study conducted in the New Jersey Medicaid program analyzed the disparities 
in PPD diagnosis and treatment between white women and women of color. This study determined 
that rates of PPD do not vary between different races; 8% of all women, regardless of race, 
screened positive for major depressive disorders and 23% for all depressive disorders within the 
first three months of motherhood (Kozhimannil et al., 2013). The differences, however, are in rates 
of detection and treatment. Kozhimmannil et al. (2013) hypothesized that lower rates of detection 
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and treatment among women of color are linked to different expectations of motherhood and the 
acceptability of mental health treatment within the culture and family unit. A difference was also 
found between white women and women of color in risk factors (Kozhimannil et al., 2013).  
Risk factors for perinatal depression are low socioeconomic status, poor access to health 
care, being single, previous history of depression or mental illness, financial instability, high-risk 
pregnancy and difficult delivery among others. Age has also been found to be a risk factor for 
perinatal depression as metabolic rate, serotonin and tryptophan development are all linked to 
increased cases of PPD and these biological responses decrease as we age (Ghaedrahmati et al., 
2017). Due to racial inequality and systemic racism built into healthcare, housing, and economic 
systems that determine quality of life in the U.S., women of color are already more likely to be 
predisposed to risk factors, increasing their chances of developing perinatal depression as well as 
other life-threatening disorders associated with pregnancy and delivery.  
While the researchers in the Kozhimmanil et al. (2013) study determined that the 
prevalence of PPD among women of different racial and ethnic backgrounds is the same, they 
reported significantly different statistics surrounding the initiation and length of care. The vast 
majority of the women in their study did not receive the services and level of care that they needed, 
and those numbers were disproportionately higher for the black and Latina women. The black and 
Latina participants were less likely to initiate conversations around mental health with their 
providers, and the white participants were twice as likely to start any kind of treatment. For the 
women of color who did initiate discussions about depression with their providers, the time it took 
to receive any kind of care or treatment was significantly longer than for their white counterparts. 
The black and Latina participants who received care were less likely to have follow-up or 
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prolonged treatment, and the researchers found that there was also a difference in the type of care 
being given.  
White participants were more likely to receive antidepressant medication while black and 
Latina participants often received only outpatient counseling. Barriers to care for minority women 
included stigma, lack of proper communication on behalf of the provider, and logistical issues such 
as transportation availability and access to childcare (Kozhimannil et al., 2013). Racism and 
provider bias in the healthcare system greatly contribute to the immense disparities seen in all 
aspects of minority health. Increased risk factors and decreased levels of treatment impact not only 
the mother, but all members of the family as well.  
2.1 Health Outcomes for Women who Experience Perinatal Depression 
Women experiencing any form of perinatal depression typically suffer from various 
detrimental symptoms that can affect their lives for as little as a few weeks up to a year. These 
symptoms do not always go away once the postpartum period is over.  Recent research has shown 
that adverse effects of perinatal and postpartum depression can continue following the mother 
years after her pregnancy and birth. A 2018 study published by the World Health Organization 
sought to determine the effects of PPD on the mental and physical health of women diagnosed 
with this condition four years after they had given birth. The tool used for depression screening 
was the EPDS and women were screened three times: during pregnancy, at 12 weeks postpartum, 
and again four years later. The average age of participants in this study was approximately 30 years 
old and a total of 671 out of the original 691 participants completed all of the needed information 
and follow-up (Abdollahi & Zarghami, 2018). The results of this study were that women who 
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previously screened positive for perinatal depression screened positive for current depression three 
times more than those who did not. Women who were previously afflicted with perinatal 
depression experienced psychological distress at a 2.3 times higher rate than those who did not 
experience depression during or after pregnancy (Abdollahi & Zarghami, 2018).  
A systematic review published in the Women’s Health Journal analyzed the adverse effects 
of PPD on relationships with the partner and other members of the woman’s social network 
(Slomian et al., 2019). The researchers found that women who experienced perinatal depression 
had overall more relationship difficulties and fewer social interactions than women who did not 
experience depression in early motherhood. Depressed mothers also reported lower levels of social 
support and were less likely to reach out to loved ones if they were in need (Slomian et al., 2019). 
There has been a surge of recent research looking at whether PPD can impact women on a 
physical and chronic health level as well. A study (Groer & Morgan, 2007) sought to determine if 
there was a connection between PPD and immune system response. The researchers excluded 
women from the study who were previously diagnosed with depression to limit confounding 
factors.  
The participants with PPD had significantly lower levels of cortisol in their saliva; cortisol 
is a stress hormone that increases sugar levels in the blood stream and assists in tissue repair (Mayo 
Clinic, 2019). Depressed participants also reported more than twice as high levels of fatigue, high 
levels of daytime sleepiness, and more frequent symptoms of infection in the four to six weeks 
after their baby had been born (Groer & Morgan, 2007). Depressed mothers in this study were less 
likely to breastfeed (32%) compared to 55% of non-depressed mothers. Participants with 
depression also had lower serum-prolactin levels, meaning they may have had difficulty producing 
milk for their child (Groer & Morgan, 2007).   
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Perinatal and postpartum depression impact the mother in a multitude of ways, and 
researchers have just begun to scratch the surface of what the long-term effects can be. Mothers 
with depression are more likely to smoke cigarettes and use illicit substances, which can contribute 
to a possible increase in risk for developing chronic illnesses later in life (Bezrutczyk, 2019). 
Negative outcomes do not shape just the mother, but the child and the whole family as well. 
Mothers with PPD are less likely to provide routine and preventative care for their children, and 
consequences of this, among many other developmental complications, can impact the child 
throughout the lifespan in drastic ways (Groer & Morgan, 2007, Muzik & Borovska, 2010).   
 
2.1.1 Impacts of Perinatal Depression on the Family 
Perinatal and postpartum depression not only impact the mother, but also can lead to 
adverse outcomes experienced by the child and other family members as well. If the mother is 
experiencing depression during her pregnancy, the infant is at a higher risk of being born premature 
and underdeveloped (Muzik & Borovska, 2010).  
Infants who are born to mothers with depression tend to have lower birth weights and are 
at a higher risk for undernutrition and growth limitations (Groer & Morgan, 2007). The first six 
months of an infant’s life are extremely important for proper physical, emotional, and 
psychological development (Abdollahi et al., 2017). New mothers who have debilitating 
depressive symptoms are less likely to engage and bond with their newborn adequately; this lack 
of connection can have lifelong consequences for the child (Muzik & Borovska, 2010). When their 
child is an infant, mothers with depression typically have one of two forms of interactive patterns 
with the child, intrusive and withdrawn. While both interaction styles impact the infant’s 
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developing coping mechanisms, infants who experience intrusive interactions tend to develop 
protective and angry coping styles, while infants who experience withdrawn maternal interaction 
are often unable to properly cope or self-regulate and tend to display their own withdrawn or 
passive behaviors ("Maternal depression and child development," 2004). 
 Mothers with depression tend to be less responsive to and interactive with their children; 
this can lead to behavioral and cognitive developmental issues and delays as the child ages. These 
children tend to be less mature than others their age and are passively non-compliant ("Maternal 
depression and child development," 2004). A longitudinal study (Abdollahi et al., 2017) found that 
women with PPD and chronic depression were significantly more likely to have a child who 
developed communication disabilities, as well as cognitive developmental delays and difficulty 
grasping new concepts. Studies have found that boys are more sensitive to the effects of maternal 
depression than girls (Abdollahi et al., 2017 & “Maternal Depression and Child Development,” 
2004).  
As toddlers, children with depressed mothers tend to display more aggressive and 
destructive behaviors. They are less likely to engage in play with their peers and can respond 
negatively to positive interactions (“Maternal Depression and Child Development,” 2004). 
Women who are experiencing depression in the years after childbirth have higher levels of negative 
mother-child interactions. This has been shown to lead to non-compliance by the child, as well as 
difficulties regulating and expressing emotions (Dietz et al., 2009). 
As the child continues to age and develop, behavioral and psychological impacts of 
maternal depression become more apparent. School age children with depressed mothers tend to 
display difficulties with internalizing and externalizing their problems (“Maternal Depression and 
Child Development,” 2004). These children are also more likely to develop psychological 
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disorders such as depression, anxiety, and conduct disorders (“Maternal Depression and Child 
Development,” 2004).  
As far as academic development, these children have a higher risk of developing attention 
deficit and hyperactive disorder (ADHD) and tend to have difficulty retaining and demonstrating 
information learned in an academic setting (Hay et al., 2001; “Maternal Depression and Child 
Development,” 2004). A longitudinal study (Hay et al., 2001) conducted in South London found 
that out of 132 students, the children with depressed mothers had on average lower IQ scores, 
difficulty paying attention, difficulty with mathematical reasoning, and a higher chance of having 
or developing special educational needs (Hay et al., 2001).  
In the adolescent to young adult years, children of depressed mothers are at an increased 
risk for developing psychological and social complications. Multiple studies have found these 
teenagers and young adults are at a significantly increased risk for developing major depression, 
anxiety disorders, conduct issues, and substance abuse problems (“Maternal Depression and Child 
Development,” 2004;  Hirsch et al., 1985). Major depression is most likely to occur between the 
ages of 15 and 20 for children of depressed mothers; they also have higher than average rates of 
developing more than one psychological disorder (Beardslee et al., 1992; “Maternal Depression 
and Child Development,” 2004).  
These trends in psychosocial differences and risks persist and can follow the child 
throughout the lifespan. Women who are pregnant have a greater likelihood of developing 
maternal depression themselves if their mothers had it, continuing the cycle of devastating illness 
that is often not discussed within families or medical facilities (Silverman et al., 2017).  
A qualitative study published in January of 2020 (Johansson et al., 2020) sought to better 
understand the lived experiences of PPD among not only mothers, but fathers as well. Paternal 
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postpartum depression is thought to affect between 4 to 25% of all new fathers, and men are 2.5 
times more likely to develop depression if their partner begins displaying symptoms (Matthey et 
al., 2000). The study found that while one partner being depressed can greatly impact the other, 
the symptoms and actions of depression present themselves in vastly different ways between the 
sexes (Johansson et al., 2020).  
While both parents with depressive symptoms found themselves feeling ill equipped to 
care for their child, fathers were more often stressed about external conditions, such as work and 
finances, and mothers expressed more internal concerns such as childcare, family relationships, 
and domestic obligations (Johansson et al., 2020). Depression for both sexes was more likely if 
the woman had a difficult pregnancy or traumatic birth, and many participants noted the lack of 
resources or coping mechanisms available to them after the traumatic experience occurred 
(Johansson et al., 2020). 
Maternal and paternal depression can lead to strains on a couple’s relationship that often 
present in numerous ways. Lack of communication and quality time can increase the burden on 
each individual differently; many women in this study became frustrated and angry with their 
partner for being unavailable to them and the child, yet the fathers often felt they were causing 
more harm than good and that it would be better to let the mother handle most of the infant care 
(Johansson et al., 2020). An increase in workload often leads to a decrease in intimacy, which was 
a point of frustration for many study participants. The mothers were much more likely than the 
fathers to disclose that they were feeling symptoms of depression, which aligns with societal 




While maternal depression has been studied much more than paternal depression, both can 
have significant impacts on the child, partner, and family. Women with PPD often experience 
relationship distress and dissatisfaction; lack of proper communication channels and adequate 
treatment can often cause depressive symptoms to develop into more severe issues (Roux et al., 
2002). Perinatal depression, for either parent, can lead to an increase in substance use, risky 
behavior, marital friction, and even divorce or separation (Johansson et al., 2020; Roux et al., 
2002).  
Overall, perinatal and postpartum depression can affect more than just the mother. 
Symptoms and adverse effects can stem from many different sources and spread in a vast number 
of ways (Johansson et al., 2020). The best strategy to mitigate the impact of perinatal depression 
on everyone involved is to screen women for depression both during and after pregnancy, as well 





As is apparent from the aforementioned research, there are multiple gaps regarding the 
understanding, diagnosis and treatment of perinatal depression for women in our society; there is 
more research to be done on how these gaps begin and why they continue to exist. ACOG, the 
leading source of practice guidelines for obstetric care providers in the U.S., has been educating 
the public and the medical community on perinatal and postpartum depression for decades. In its 
most recent practice guidelines given to obstetric providers in 2018, it stated this regarding mental 
health screening in pregnancy:  
The American College of Obstetricians and Gynecologists recommends that obstetrician-    
gynecologists and other obstetric care providers screen patients at least once during the  
perinatal period for depression and anxiety symptoms using a standardized, validated tool.  
It is recommended that all obstetrician-gynecologists and other obstetric care providers  
complete a full assessment of mood and emotional well-being (including screening for  
postpartum depression and anxiety with a validated instrument) during the comprehensive  
postpartum visit for each patient. If a patient is screened for depression and anxiety during  
pregnancy, additional screening should then occur during the comprehensive postpartum 
 visit (ACOG, 2018, p.1).  
To evaluate whether providers were following these guidelines given by ACOG and to 
determine how they were communicating information to their patients, research was conducted. 
We performed a post-hoc analysis of a subset of data collected in a larger study, Talking to 
Pregnant Patients (T2P2), that included audio-recorded conversations between pregnant patients 
and their obstetric care providers during the first obstetric visit, patient and provider demographic 
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data, and medical record data from the pregnancy records. The data for this original study was 
collected from 2011 to 2015. This was an NIH funded observational study that looked to better 
understand patient-provider communication and health outcomes regarding substance use in 
pregnancy (Chang et al., 2017). The original study’s main goal was to “identify communication 
styles and processes that encourage pregnant, substance-using women to disclose alcohol or illicit 
drug use and subsequently result in conversations that promote the adoption of positive behaviors” 
(Olaniyan, 2020, p. 68). 
3.1 Data Selection 
This current analysis was conducted under the direction of Abisola Olaniyan, a PhD 
candidate in the Department of Behavioral and Community Health Sciences at the University of 
Pittsburgh’s Graduate School of Public Health, and Dr. Judy Chang, an OBGYN and Associate 
Professor at the University of Pittsburgh’s Medical School in the Department of Obstetrics, 
Gynecology and Reproductive Sciences. Our team also included Anna Patterson, an MPH student 
in the Department of Health Policy and Management who is a Registered Nurse. This research 
team collected information from audio recordings of the first visit by pregnant patients with an 
obstetric care provider (Chang et al., 2017). These visits had been transcribed with the names of 
the patients and providers removed to maintain confidentiality. Participating women and their 
medical providers agreed to partake in the T2P2 study that allowed an audio recording of their first 
obstetric visit.  
Following the first obstetric visit, the patient completed a post-visit questionnaire and an 
interview with a member of the research team to talk about how they felt their provider handled 
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the appointment and the topic of substance use in pregnancy. In addition to providing these 
qualitative data, the research team also collected urine samples from patient participants to test for 
illegal drugs and substances. The study team then obtained patient medical records and 
demographic information, selecting 88 women to interview within four weeks of their first visit 
who met the following requirements: a positive test for any illegal substance in a drug screen, 
verbal confirmation to their provider that they used substances, and a disclosure of alcohol 
consumption on the post-appointment questionnaire (Chang et al., 2017; Olaniyan, 2020).  
Out of the 88 women who completed an interview, 80 had the necessary comprehensive 
data file to be included in this analysis: an audio recording of their first prenatal visit, a written 
transcript of the first prenatal visit, the type of the provider who completed the visit, and the ability 
to access medical records to obtain further patient information if necessary. These records were 
also supposed to include a score from the EPDS, the depression screening tool that all providers 
are to give their patient during their first prenatal visit. Out of the 80 participants who were selected 
for this study, 25 did not have an EPDS on file, meaning they were likely not screened for 
depressive symptoms (J. Chang, personal communication, September 3, 2020). 
 
3.1.1 Participants 
To qualify for this study, patients had to be pregnant, 18 years of age or older, English 
speaking, and having their first obstetric appointment for this pregnancy with a participating 
provider (Chang et al., 2017; Olaniyan, 2020). Providers were eligible to participate if they were 
seeing the patient for her first obstetric visit for that pregnancy at their current medical facility 
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(Olaniyan, 2020). These obstetric visits took place and were recorded at five urban outpatient 
gynecological clinics located in Pittsburgh, Pennsylvania (Chang et al., 2017). 
All participants in this study signed informed consent forms for the data collection process 
that took place between December 2011 and May 2015 (Chang et al., 2019). They were told the 
study was focusing on patient-provider communication but were not initially informed of the 
substance use focus as the researchers did not want that knowledge impacting the responses of the 
patients or the demeanor of the providers. The participant pool was racially diverse and included 
women from mostly lower socio-economic backgrounds (Olaniyan, 2020).  
 
3.1.1.1 Data Analysis 
 
Our research team coded 80 transcripts of the first obstetric visit and organized this analysis 
using a software called NVIVO. This coding software allows researchers to conduct mixed-
methods analysis effectively, helping the user organize and analyze the text to find patterns, 
discrepancies, and various other important factors that helped fuel and defend this research (QSR 
International, 2020). While coding these recordings, we were looking specifically at three main 
questions: 
• Did the provider ask about the patient’s mental health history in any capacity? 
• Did the provider communicate the risk of perinatal or postpartum depression to the patient? 
• Did the patient disclose any current or previous mental illness? 
After we listened for this information in the audio recordings and coded the conversation 
in NVIVO, we documented our findings in an Excel spreadsheet. These findings included a yes/no 
answer to the three aforementioned research questions as well as the title of the provider.  
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Once the data were coded, it was important for us to distinguish not only the 
communication styles displayed by different providers, but also if racial and demographic 
differences of the patients may have played a role in whether or not they were given information 




Our research team coded and analyzed 80 case files looking for discussions between 
patients and their providers about mental health and perinatal and postpartum depression. Three 
types of providers participated in this research project: physicians, nurse midwives, and nurse 
practitioners. We found it was important to include the provider’s title in our research findings to 
determine if there were any differences in how certain providers addressed the topic of mental 
health and if some providers were more inclined to discuss mental health in pregnancy than others. 
Patient information such as race and EPDS score were also analyzed, the table below shows a brief 
summary of those demographics.  
 
Table 1: Patient Information 
Patient Race White: 21 Black: 50 Multiracial: 8 Unreported: 1 Total: 80 
EPDS Scores 0-8: 36 9-11: 3 12-14: 5 15+: 11 Total: 55 
 
 
For the 80 obstetric visits we listened to and coded, 56 of the providers were physicians, 
19 were nurse practitioners, and five were nurse midwifes. Our analysis shows that the provider 
asked about the patient’s current or previous mental health history at 33 of the 80 visits, meaning 
that only 41.2% of these patients were asked about their mental health. When providers are divided 
by type, these numbers are even more disparate. Out of the 56 cases in which the provider was a 
physician, only 14 patients were asked about their mental health history; 75% of patients who were 
seen by a physician were not asked about their mental health in any capacity. The opposite can be 
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said for the nurse practitioners in the study; 16 of the 19 patients seen by a nurse practitioner were 
asked about their mental health, meaning that 84.2% of all patients seen by a nurse practitioner 
had the opportunity for a discussion on mental health. Midwives were the providers for only five 
out of the 80 patients, but out of the five visits they did have, three of them (60%) asked about 
mental health. Table 4, located in Appendix A, shows the record of which patients were and were 
not asked about their mental health history, broken up by the patient’s EPDS score if it was 
provided, provider title, if perinatal or postpartum depression was discussed, and if the patient 
disclosed any previous or current mental health problems. 
The study also looked for whether or not the provider brought up the topics of perinatal or 
postpartum depression. This was important to measure as previous research showed that 80% of 
all cases of perinatal depressive symptoms occur during pregnancy, and 1/3 of those women 
experienced the symptoms in the first trimester (Wilcox et al., 2020). ACOG recommends that 
screening for depressive symptoms and asking about the patient’s mood should occur at the first 
appointment to better monitor the course of a patient’s symptoms and to advise the patient on what 
is abnormal in pregnancy ("ACOG Committee Opinion No. 757: Screening for Perinatal 
Depression," 2018). 
In our data set, only nine out of the 80 patients had a provider who initiated a conversation 
about perinatal and postpartum depression. Out of those nine patients, eight had disclosed either 
past or current mental illness, which is known to be a risk factor for developing perinatal or 
postpartum depression (Ghaedrahmati et al., 2017). Of the 80 patients we studied, 23 of them 
disclosed either current or past mental illness, and even though we know they are at higher risk for 
developing any form of maternal depression, only eight out of 23, or 34.8%, of providers brought 
this up to their patients to inform them of the risk. Table 2 shows the data related to the nine 
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patients who were educated about PPD, including their EPDS score, the title of the provider, and 
what type of mental illness was disclosed. 
 
Table 2: Data collected from patients who received PPD information 








If yes, what type? 
Not recorded  Nurse 
Practitioner  
Yes No N/A 
5 Nurse 
Practitioner  
Yes Yes Depression 
15 Physician Yes Yes Depression, PPD 
1 Nurse 
Practitioner  
Yes Yes Mood disorders  
8 Physician  Yes Yes Depression, 
Anxiety 
Not recorded  Physician  No Yes Current PPD 
17 Physician  Yes Yes Depression, PPD 
Not recorded  Physician  Yes Yes Depression, 
Anxiety 
Not recorded  Physician  Yes Yes Depression  
 
 
The data in the table above show that perinatal and postpartum depression were discussed 
at nine of the 80 (11.3%) visits. Physicians, who saw 56 of the patients, had this necessary 
conversation with only six (10.7%) of them. Nurse Practitioners discussed PPD with three out of 
their 19 patients (15.8%), none of the five midwives initiated this conversation (0%).  
As previously mentioned, all patients in this study were to be screened for depressive 
symptoms with the EPDS at their first visit. Only 55 out of the 80 participants had this assessment 
on file, meaning that potentially 31.3% of all patients were not screened with this tool (J. Chang, 
personal communication, September 3, 2020). These findings go against the current standards 
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created by ACOG, as well as those encouraged by UPMC, that all patients be screened for 
depressive symptoms at the first obstetric care visit ("ACOG Committee Opinion No. 757: 
Screening for Perinatal Depression," 2018; Chaudron et at., 2010). 
Out of the 55 participants who were administered the EPDS, 36 of them screened not likely 
for depression, three of them screened possible for depression, five screened to have a fairly high 
probability for depression, and 11 scored to have probable depression. Of the 19 who scored 
positive for any depressive symptoms, 12 were asked by their provider about their mental health 
history. For the seven patients who screened positive for symptoms but were not asked, all the 
providers were physicians. A more detailed breakdown of the data for the 55 EPDS scores is shown 
in Table 3. The EPDS scores are broken into four categories dictating the likelihood of depression, 




Table 3: EPDS Findings and Likelihood of Depression 
0 to 8- Depression 
not likely 
9 to 11- Possible 
depression 
12 to 13- High probability 
of depression 





Yes Physician- No Nurse Practitioner- Yes 
Midwife- Yes Physician- No Physician- Yes Nurse Practitioner- Yes 
Nurse Practitioner-
Yes Physician- No Nurse Practitioner- Yes Physician- Yes 
Nurse Practitioner-
Yes  Physician- No Physician- Yes 
Nurse Practitioner-
Yes  Physician- Yes Physician- No 
Nurse Practitioner-
Yes   Physician- Yes 
Midwife- Yes   Physician- Yes 
Physician- No   Nurse Practitioner- Yes 
Nurse Practitioner-
Yes   Physician- No 
Physician- Yes   Physician- No 
Nurse Practitioner-
Yes   Physician- No 
Physician- No    
Physician- No    
Physician- No    
Physician- No    
Physician- Yes    
Midwife- No    
Physician- No    
Physician- No    
Physician- No    
Physician- No    
Physician- Yes    
Nurse Practitioner-
Yes    
Nurse Practitioner- 
No    
Nurse Practitioner-
Yes    
Nurse Practitioner-
Yes    
Physician- No    
Physician- No    
Physician- No    
Physician- No    
Physician- No    
Physician- No    
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Physician- No    
Physician- No    
Physician- No    
Physician- No    
 
 
A previous study (Kozhimannil et al., 2013) showed that black women are 
disproportionately under screened and less likely to be treated for perinatal and postpartum 
depression. This was an important aspect of our study that warranted further analysis to better 
understand if the race of the patient impacted the likelihood of these necessary conversations taking 
place in Pittsburgh, Pennsylvania. Out of the 80 participants in our study, 79 of them had their race 
documented in their medical charts. The following data analysis is reflective of the 79 patients 
whose race was disclosed.  
Twenty-one out of the 79 patients were white (26.6%), 50 were black (63.3%), and eight 
identified as bi- or multiracial (10.1%), with at least one of their races being black. For the 21 
white participants, 10 (48%) were asked about their mental health history while 11 were not. 
Physicians asked their white patients 37.5% of the time (six out of 16), nurse practitioners asked 
100% of the time (two of two), and nurse midwives asked 66.7% of the time (two out of three).  
Out of the 50 patients in our study who identified as black, 19 (40%) of them were asked 
about their mental health by providers. Thirty-five of the black participants saw a physician as 
their provider, and only seven of them (20%) were asked about their mental health. Fourteen of all 
black patients were seen by nurse practitioners, and 11 of them (78.6%), were asked about their 
mental health history. Only one patient in this racial group saw a midwife, and there was a 
discussion about mental health (100%). 
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Of the eight participants who identified as bi or multiracial, four (50%) of them were asked 
about their mental health in general. Patients who saw a physician were asked 25% of the time 
(one in four), nurse practitioners asked 100% of the time (three of three) and midwives asked 0% 
of the time (zero out of one).  
While there are only 21 white participants in this study, this begins to suggest possible 
racial disparities as white women were more likely than any other racial group to be asked about 




This research study explored how obstetric providers speak to their patients about mental 
health. The primary goals were to see how many patients were given the opportunity to discuss 
their mental health, which providers were initiating these conversations and what those 
conversations looked like. Screening for and treating perinatal and postpartum depression are 
extremely important to the overall health of the mother and child, and our study has shown that 
obstetric providers in the Pittsburgh area are not following the recommended guidelines, 
contributing to the greater lack of understanding, diagnosis and treatment of PPD.  
Recommendations for early and multiple mood screenings for pregnant women have been 
in place since the early 2000s (Management, 2010). In 2002, the U.S. Preventative Task Force 
published a report that recommended women be screened early and often for depressive symptoms 
in pregnancy, finding that screening increased the number of adults who were accurately diagnosed 
with depression and that subsequent treatment decreased overall clinical morbidity ("Screening for 
depression: recommendations and rationale," 2002). 
Because only 41.2% of the patients in our study were asked about their mental health, we 
can say that at least for this sample, recommended guidelines are not being followed. To ensure 
that all women are given the opportunity to discuss their mood and possible concerns with their 
provider, these guidelines need to be required for all providers who are caring for pregnant patients. 
It is also important to recognize the differences across provider type in this study. Only 25% of 
patients who saw a physician had a discussion about mental health, yet 84.2% of nurse practitioners 
and 60% of nurse midwives initiated this conversation with their patients.  
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Research shows that up to 51% of women who experience socioeconomic hardships report 
depressive symptoms during and after pregnancy (Muzik & Borovska, 2010). Women who use 
illicit substances prior to, during, or after pregnancy are also at an increased risk for developing 
perinatal depression (Bezrutczyk, 2019). When considering the pool selected to participate in this 
study, the results are even more surprising. The majority of our study participants were at a higher 
risk for developing perinatal and postpartum depression because of those factors alone, so all 
providers, regardless of type, should have been actively screening them for symptoms.  
Differences in screening rates across provider types can possibly be attributed to 
differences in education and training. This could also be caused by other factors such as physicians 
thinking one of the other staff members is responsible for screening. Universal standards need to 
be established so that every woman, regardless of her provider, has equal access to the necessary 
screenings. Many women who are experiencing symptoms of depression do not report them, but 
with proper screening systems put into place that can change (Avalos et al., 2016). 
5.1 Prevalence  
The study found that only 68.8% of patients were screened for depressive symptoms 
using the EPDS, which was unexpected. Sixteen out of the 55 screened patients showed a high 
probability of having depression, yet only 62.5% of them were asked about it by their provider. 
Of all 80 patients, 19 of them were not screened with the EPDS or asked about their mental 
health by a provider, meaning that 23.8% of all patient participants received zero opportunity to 
document or discuss their mental health. The data found in this study show that maternal mental 




To decrease the incidence of perinatal and postpartum depression in the United States, 
pregnant women need to be screened on a regular basis for potential signs and symptoms and 
given adequate, equal access to proven treatment. To do this, medical professionals need to be 
trained on multiple issues:  
• Administering the Edinburgh Postnatal Depression Scale (EPDS), Beck’s 
Depression Inventory (BDI), or the Patient Health Questionnaire (PHQ-9). 
• Using these diagnostic screening tools, as well as other forms of gathering 
information, at every obstetric visit throughout the patient’s pregnancy. 
• Asking every single patient, regardless of screening tool score, if they have a 
history of depression or mental illness, how their mood has been since the 
beginning of this pregnancy, and if there is a history of PPD in the maternal side 
of their family at the first comprehensive visit. 
• Developing skills in communication, rapport building, and establishing trust with 
the patient.  
As far as deciding which screening tool to use, three main questionnaires that screen for 
depressive symptoms are used regularly in the United States: the EPDS, BDI, and PHQ-9. The 
screening tool used in this study was the EPDS, one of the most commonly used depression 
screening tool for women during and after pregnancy (Timsit, 2019). A study (Petrozzi & 
Gagliardi, 2013) found that the EPDS can also be successful in detecting anxiety symptoms 
because it is one of the only screening tools that includes three questions specifically regarding 
anxiety (Timsit, 2019). 
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The EPDS and PHQ-9 are similar in structure as both have 10 straightforward questions 
that determine if the participant is experiencing depressive symptoms. The EPDS asks if the 
patient has been experiencing these symptoms in the past seven days, while the PHQ-9 asks if 
they have occurred in the past two weeks (Timsit, 2019). Some providers think the PHQ-9 is not 
as accurate as the EPDS, but it is important to note that both of these screening tools have come 
under scrutiny for not being language-inclusive for people of all race, economic, and educational 
backgrounds (Timsit, 2019; Di Florio et el., 2016). 
A 2016 study (Di Florio et al., 2017) used ordinal regression and measurement invariance 
to determine if there was a relationship between demographic factors such as race, education, 
culture, and the effectiveness of the EPDS. The study found that educational background was the 
largest contributor to inaccurate EPDS scores for new mothers. Obstetric care providers need to 
be aware of educational and cultural differences that can contribute to flawed reporting on the 
EPDS and other depression measurement scales (Di Florio et al., 2017). Having this knowledge 
will allow providers to better screen for depression through other mechanisms such as 
conversation, body language, and overall health.  
The BDI can be used by a trained provider to determine if a patient is experiencing 
depressive symptoms. This screening questionnaire contains 21 questions that are broader than 
either the EPDS or PHQ-9. This tool, however, was not designed specifically for identifying 
depression during or after pregnancy. It is used to gauge the severity of depressive symptoms in 
patients who already meet the threshold for depression, so it is recommended that obstetric care 
providers use this screening tool only for patients who already appear depressed or who have 
screened positive on either the EPDS or PHQ-9 (Edelstein et al., 2004).  
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Screening for depressive symptoms, both during and after pregnancy, needs to be a 
mandatory part of every woman’s obstetric care routine, regardless of location or provider. 
Several states have passed legislation mandating depression screening for postpartum women as 
well as mandating that educational material be provided to women on the risks and symptoms of 
postpartum depression (Rhodes & Segre, 2013). These mandates, however, do not cover the 
topic of screening for depression during pregnancy and often are not followed in an effective 
manner (Rhodes & Segre, 2013). 
An issue that has arisen from this legislation is that once women do screen positive for 
depressive symptoms, not many resources are in place for them to get treatment (Timsit, 2019). 
A published review of U.S. laws and legislation regarding state mandated screenings found that 
even when the policies are mandated on a large scale, it does not guarantee that every clinic and 
hospital system is implementing and following the guidelines (Rhodes & Segre, 2013). For these 
states, funds have not been distributed adequately and some smaller practices were not receiving 
the same resources as larger hospital systems, creating a gap in their ability to enforce the 
mandate. “Best practices” were often not achieved as access was not the same statewide (Rhodes 
& Segre, 2013). 
To mitigate this issue, the best way to implement mandatory screenings would be on a 
local level, allowing hospitals and clinics to create their own procedures through financial 
resources provided by the state government. The main goal is to get every patient screened, 
every time they are seen. If funds are not being distributed equitably, this will likely continue to 
affect lower income communities more severely. By creating a mandatory state allocated budget 
rather than just a mandated guideline, every woman attending obstetric care visits will have 
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access to the same resources, regardless of location or health care system (Rhodes & Segre, 
2013; Timsit, 2019). 
Even after a woman is diagnosed, current barriers in our health care and social service 
systems prevent most of them from seeking or completing any form of treatment (Kozhimannil 
et al., 2013). We can alter the course of this issue by implementing procedures that must be 
followed once a patient receives a certain score on the EPDS or other screening tool. First steps 
would include a mandatory evaluation from a mental health professional within one week of 
receiving this result. Depending on the results of the evaluation, the provider will either 
recommend continual monitoring of symptoms or the patient will discuss other options with the 
designated medical provider.   
Regardless of the result of the evaluation, patients should continue to be screened on a 
regular basis to monitor for adverse symptoms. A 2019 study based in Hong Kong, China (Chan 
et al., 2019), consisted of 660 women at 24 weeks gestation who were all receiving regular 
prenatal care. Three hundred thirty of these women were also given an intervention of a 
psychoeducational mobile app for their smartphone to monitor and educate them on mental 
health during pregnancy. The women in the study who received the intervention had significantly 
reduced postnatal depression at four weeks postpartum compared to the control group. These 
women also recorded lower stress levels and were more likely to attend all necessary medical 
visits (Chan et al., 2019).  
While the research and technology are rather new, a mobile app that women could use to 
monitor their symptoms from home appears be extremely beneficial. Some women do not want 
to disclose depressive symptoms to their provider even if they are asked, and a potential issue 
with the EPDS and other screening tests is that people can lie about their symptoms to avoid 
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unwanted opinions or treatment (Management, 2010). If women have the ability to access 
screening tools and educational information from the privacy of their own home, they may be 
more likely to answer questions honestly and read the educational material that corresponds to 
their answers.  
Overall, the issues of underdiagnosing and not treating maternal depression do not stem 
from one obstacle in particular. Various barriers exist that prevent women from obtaining the 
information and education needed to protect their mental health both during and after pregnancy. 
Increasing obstetric provider education and training is a necessary step so that all providers are 
asking the proper questions and evaluating their patients for depression. Funding needs to be 
allocated to all obstetric care facilities to allow these screenings and evaluations to take place. 
Once women are being properly diagnosed and treatments are initiated, we will greatly improve 







The terms perinatal and postpartum depression encompass multiple mental illnesses that 
can be extremely dangerous to women who are affected. Perinatal depressive symptoms can begin 
as early as the first trimester of pregnancy and can continue for months or years after delivery. 
There are five main forms of PPD: baby blues, postpartum depression, postpartum anxiety, 
postpartum panic disorder, and postpartum psychosis (Thurgood et al., 2009; House et al., 2016).  
While minor emotional changes are to be expected during pregnancy and after delivery, 
women who experience the aforementioned illnesses may be subjected to long-term impacts that 
negatively affect the health and well-being of the entire family. Women with PPD are at an 
increased risk of developing long-term depression, additional mental illnesses, and chronic health 
problems (Groer & Morgan, 2007, Muzik & Borovska, 2010).   
Children of depressed mothers are at increased risk for developing mental illnesses, 
behavioral issues and intellectual difficulties (Groer & Morgan, 2007; "Maternal depression and 
child development," 2004). Babies born to depressed mothers are at a higher risk of being low 
birth weight; these children are also less likely to receive the routine care needed for proper 
emotional and intellectual development which often continues the cycle of mental illness in the 
family (Abdollahi et al., 2017; "Maternal depression and child development," 2004).  
Male partners of women with PPD were found to be 2.5 times more likely to develop 
depression themselves (Matthey et al., 2000). This can add to the mental and emotional strains of 
parenthood and potentially cause irreparable damage to the relationship of the couple (Johansson 
et al., 2020).  
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In most of the visits studied for this research, obstetric care providers did not ask their 
patients about mental health in any capacity. This is contributing to much larger issues such as 
perinatal and postpartum depression, maternal and infant health, and even maternal mortality. 
Perinatal and postpartum depression effects between 12-20% of new mothers within the first year 
of delivery and often goes undiagnosed (Avalos et al., 2016). To effectively diagnose and treat 
women who experience this form of mental illness, universal standards need to be put in place and 
be mandated for every obstetric care provider. A screening tool needs to be used at every obstetric 
care visit for the duration of a woman’s pregnancy. All obstetric care providers, regardless of title, 
need to be properly trained on how to administer these screening tools, how to approach the 
conversation of mental health, and how to recognize the non-verbal signs and symptoms that their 
patient may be struggling with perinatal depression.  
6.1 Limitations  
Our study, completed with the T2P2 data, strove to understand the relationship between 
provider communication and patient discussion of mental health in pregnancy. While we had a 
substantial amount of data to analyze, this study had limitations. 
As we look at our results in comparison to one another, there is already a noticeable 
distinction, specifically for physicians, regarding patient race and the discussion of mental health 
history. While the previous overall analysis showed that physicians asked their patients about 
mental health only 25% of the time, race could possibly be a contributing factor as to when these 
discussions occur. Physicians asked their white patients 37.5% of the time, their black patients 
20% of the time, and bi or multiracial patients 25% of the time.  
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While this data set may not be large enough to draw conclusions on the contrast between 
patient race and perinatal depression screening accessibility, it supports previous research that has 
found that women of color have less access to necessary tools needed to have a healthy pregnancy 
and postpartum period (Kozhimannil et al., 2011).  
Additional limitations are that the providers selected for this study worked only for the 
UPMC hospital system. It is possible that other obstetric providers, either locally, statewide, or 
nationally, operate under different screening requirements and do require discussions on mental 
health. Also, only five of the 80 providers were midwives, meaning the quantity of data collected 
was not substantial enough to show whether midwives asked about maternal mental health at a 
higher or lower rate than their coworkers. The data provided through the T2P2 study were also 
purposefully selected from patients who had either disclosed or tested positive for substance use, 
making them a high-risk population that is more likely to have a history of mental illness. 
Replication with other clinics and hospital networks, specifically with women who are not deemed 
to be high-risk, is warranted (Chaudron et al., 2010).  
 
6.1.1 Implications 
Overall, perinatal and postpartum depression are the most common complications in 
pregnancy and childbirth with more than half of all cases remaining undiagnosed (Zauderer, 2009). 
Whether a patient has PPD or anxiety, postpartum panic disorder, psychosis, or even just the baby 
blues, all cases need to be taken seriously and treated properly if necessary. For all cases of 
perinatal depressive symptoms, 80% of those occur during pregnancy and 1/3 of those women 
experienced the symptoms in the first trimester (Wilcox et al., 2020). Our study has shown that 
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the highly recommended screening procedures from ACOG were not being followed by all of 
providers in the five UPMC outpatient clinics where patients were seen. All providers, regardless 
of type, need to be trained on how to appropriately implement the chosen screening tool as well as 
how to properly initiate and monitor a conversation about mental health with their patients. 
Funding must be allocated for these resources through the state and federal government, allowing 
all obstetric care offices and providers equal access to the screenings that can prevent disease 
progression and save lives. Mandatory protocols and guidelines need to be established and 
followed so all women who screen positive have the ability to receive further evaluation and 
treatment if necessary.  
Once screenings are required and all providers are equally trained and successful at 
discussing and diagnosing perinatal and postpartum depression, maternal health outcomes for 
women in the United States will improve. This will result in a higher quality of life for all families, 
decreasing mental illness incidence and increasing opportunities for a successful future (O’Conner 












Appendix A  
Table 4: Data collected from 80 T2P2 audio recordings and transcripts 
EPDS Score Type of Provider Asks about Mental Health HistoryMention Perinatal Depression or PPDDid patient disclose History of Mental Illness ? 
12 Physician No No No
Physician No No No
Physician No No No
Nurse Practitioner Yes Yes No
5 Nurse Practitioner Yes Yes Yes-Depression
7 Midwife Yes No Yes- Depression
8 Nurse Practitioner Yes No Yes- Bipolar, depression
6 Nurse Practitioner Yes No No
21 Nurse Practitioner Yes No No
0 Nurse Practitioner Yes No No
12 Nurse Practitioner Yes No No
12 Physician Yes No No
3 Nurse Practitioner Yes No No
9 Nurse Practitioner Yes No No
7 Midwife Yes No Yes- Anxiety 
2 Physician No No No
14 Nurse Practitioner Yes No No
Nurse Practitioner No No Yes- Anxiety
5 Nurse Practitioner Yes No Yes- Depression
Midwife No No Yes- Anxiety
15 Physician Yes Yes Yes- Depression, PPD
21 Physician Yes No No
Physician No No No
0 Physician Yes No Yes- Depression
Physician No No No
Physician No No No
1 Nurse Practitioner Yes Yes Yes- Mood disorders
2 Physician No No No
2 Physician No No Yes- Depression
3 Physician No No No
16 Physician No No No
Physician Yes No Yes- Anxiety, panic attacks
4 Physician No No No
Physician No No No
8 Physician Yes Yes Yes- Anxiety, Depression
13 Physician No No No
Physician No No No
14 Physician Yes No Yes- Bipolar, depression, manic, schzophrenia, boarderline personality disorder
4 Midwife No No No
Physician No No No
Midwife Yes No Yes- Depression
3 Physician No No No
Physician No No No
9 Physician No No No
8 Physician No No No
5 Physician No No No
Physician No No No
Physician No Yes Yes- Depression in pregnancy only
2 Physician No No No
2 Physician Yes No No
17 Physician Yes Yes Yes- Depression, PPD
8 Nurse Practitioner Yes No No
5 Nurse Practitioner No No Yes- Anxiety
2 Nurse Practitioner Yes No No
0 Nurse Practitioner Yes No No
Physician Yes Yes Yes- Depression, Anxiety
6 Physician No No No
20 Nurse Practitioner Yes No No
1 Physician No No No
1 Physician No No No
4 Physician No No No
2 Physician No No No
2 Physician No No Yes: Anxiety
Physician No No No
Physician No No No
14 Physician No No No
14 Physician No No No
1 Physician No No No
2 Physician No No No
9 Physician Yes No No
Nurse Practitioner No No No
12 Physician Yes No Yes: Depression, Night terrors
17 Physician No No No
3 Physician No No No
6 Physician No No No
Physician Yes No Yes: Depression
Physician Yes Yes Yes: Depression
Physician No No No
Physician No No No
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